Peptides are the next big growth area for Hims & Hers; the company acquired a Menlo Park peptide manufacturing plant and may be the only US company able to bring American-made peptides from raw ingredients to patients, with plans to launch if FDA moves peptides to category one and with clinical oversight plus home blood testing.